Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The updated page shows a revised layout and styling, but core study content (purpose, eligibility criteria, primary outcomes, enrollment, dates, and locations) appears unchanged. No significant data changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:29:07.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Core page now includes a government funding lapse notice and a new v3.2.0 release, replacing v3.1.0; this affects perceived reliability and versioning of the page.
    Difference
    5%
    Check dated 2025-10-06T08:15:19.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. This is a metadata revision with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T04:45:20.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, with no substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-14T22:35:20.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-07T19:43:27.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location to specify Washington D.C., District of Columbia, United States, while removing several previous location-related terms and resources.
    Difference
    3%
    Check dated 2025-08-31T12:28:47.000Z thumbnail image

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.